JP2025507852A5 - - Google Patents
Info
- Publication number
- JP2025507852A5 JP2025507852A5 JP2024551975A JP2024551975A JP2025507852A5 JP 2025507852 A5 JP2025507852 A5 JP 2025507852A5 JP 2024551975 A JP2024551975 A JP 2024551975A JP 2024551975 A JP2024551975 A JP 2024551975A JP 2025507852 A5 JP2025507852 A5 JP 2025507852A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- compound according
- aforementioned
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315438P | 2022-03-01 | 2022-03-01 | |
| US63/315,438 | 2022-03-01 | ||
| US202363439477P | 2023-01-17 | 2023-01-17 | |
| US63/439,477 | 2023-01-17 | ||
| PCT/US2023/014275 WO2023167925A1 (en) | 2022-03-01 | 2023-03-01 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507852A JP2025507852A (ja) | 2025-03-21 |
| JP2025507852A5 true JP2025507852A5 (https=) | 2026-03-10 |
Family
ID=85772026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024551975A Pending JP2025507852A (ja) | 2022-03-01 | 2023-03-01 | 中環状または大環状ベンジル置換複素環誘導体および関連の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250236629A1 (https=) |
| EP (1) | EP4486748A1 (https=) |
| JP (1) | JP2025507852A (https=) |
| KR (1) | KR20240157067A (https=) |
| CN (1) | CN119110802A (https=) |
| AU (1) | AU2023228830A1 (https=) |
| CA (1) | CA3245204A1 (https=) |
| CL (1) | CL2024002576A1 (https=) |
| IL (1) | IL315237A (https=) |
| MX (1) | MX2024010608A (https=) |
| TW (1) | TW202400606A (https=) |
| WO (1) | WO2023167925A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| KR20250155550A (ko) | 2023-03-16 | 2025-10-30 | 다케다 야쿠힌 고교 가부시키가이샤 | 매크로시클릭 헤테로시클 화합물 및 이의 용도 |
| US20240425521A1 (en) | 2023-06-01 | 2024-12-26 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US20200207734A1 (en) | 2017-08-03 | 2020-07-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| SG11202106791XA (en) | 2019-01-31 | 2021-07-29 | Takeda Pharmaceuticals Co | Heterocyclic compound and use thereof |
| FI4065585T3 (fi) * | 2019-11-25 | 2025-09-26 | Alkermes Inc | Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä |
| WO2022051583A1 (en) * | 2020-09-03 | 2022-03-10 | Orexia Therapeutics Limited | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists |
-
2023
- 2023-03-01 KR KR1020247032615A patent/KR20240157067A/ko active Pending
- 2023-03-01 IL IL315237A patent/IL315237A/en unknown
- 2023-03-01 WO PCT/US2023/014275 patent/WO2023167925A1/en not_active Ceased
- 2023-03-01 EP EP23713207.1A patent/EP4486748A1/en active Pending
- 2023-03-01 CN CN202380037293.8A patent/CN119110802A/zh active Pending
- 2023-03-01 TW TW112107384A patent/TW202400606A/zh unknown
- 2023-03-01 JP JP2024551975A patent/JP2025507852A/ja active Pending
- 2023-03-01 MX MX2024010608A patent/MX2024010608A/es unknown
- 2023-03-01 CA CA3245204A patent/CA3245204A1/en active Pending
- 2023-03-01 AU AU2023228830A patent/AU2023228830A1/en active Pending
-
2024
- 2024-08-28 US US18/817,943 patent/US20250236629A1/en active Pending
- 2024-08-29 CL CL2024002576A patent/CL2024002576A1/es unknown
-
2025
- 2025-04-11 US US19/177,396 patent/US20250289828A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025507852A5 (https=) | ||
| JP2023540350A5 (https=) | ||
| JP2023540344A5 (https=) | ||
| JP2023527575A5 (https=) | ||
| JP2022545633A5 (https=) | ||
| CN116438170A (zh) | 含氮桥杂环化合物、其制备方法及其在医药上的应用 | |
| TW200800221A (en) | δD-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
| AU2014237232B2 (en) | Amine functional polyamides | |
| JP2021513967A5 (https=) | ||
| JP4628975B2 (ja) | イバブラジン塩酸塩のγｄ−結晶形態、その製造方法およびそれを含む医薬組成物 | |
| JP2014528485A5 (https=) | ||
| JP2006512314A5 (https=) | ||
| JP2006504710A5 (https=) | ||
| NO338370B1 (no) | ß-krystallinsk form av ivabradin-hydroklorid, fremgangsmåte for dens fremstilling og farmasøytiske sammensetninger inneholdende den | |
| JP2006241156A (ja) | イバブラジン塩酸塩のγ−結晶形態、その製造方法およびそれを含む医薬組成物 | |
| JP2006513208A5 (https=) | ||
| JP2007112796A (ja) | 塩酸イバブラジンのδ結晶形態、その製造法、およびそれを含有する医薬組成物 | |
| RS50599B (sr) | KRISTALNI OBLIK BETA-d IVABRADIN HLORHIDRATA, POSTUPAK NJEGOVE IZRADE I FARMACEUTSKE SMEŠE KOJE GA SADRŽE | |
| JP2007519742A5 (https=) | ||
| JP2021528386A5 (https=) | ||
| JP2022174180A (ja) | 化合物、組成物および方法 | |
| JPH07508973A (ja) | 血中酸素親和性の抑制のためのヘモグロビンのアロステリック修飾剤の使用 | |
| TWI223651B (en) | Phosphonic acid derivatives having inhibitory activity against carboxypeptidase B | |
| US20100069423A1 (en) | Use of Chk2 Kinase Inhibitors for Cancer Treatment | |
| JPH05194491A (ja) | イミダゾリルメチル−ピリジン |